- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04216264
Pattern - Reach Aim 2
October 21, 2022 updated by: Duke University
Pilot Adaptive Tool To Encourage Risk Reduction in iNfancy (PATTERN)
The purpose of this research study is to learn about different approaches to promoting healthy growth among infants, and understanding parents' likes and dislikes of an approach to reducing risk factors for obesity later in life.
The study includes filling out some forms with questions about your baby and your thoughts about your baby's growth and health, and engaging in a pattern of changes in or prevention of risk factors in the first year of life.
Parents will receive information about changes and some tools and materials to take home with them.
Some parents may receive phone calls between visits as well.
The study takes place from soon after birth through the infant's age of 9 months.
The estimated total time of interaction between the study staff and parents during the study period is 4 hours.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
As this is a dyad study, each dyad is considered to be a participant and demographic information will reflect the infant in the dyad, per parent report.
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 weeks to 2 months (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Non-Hispanic black (as documented in MaestroCare) parents/caregivers with; infants ages 2 weeks to 2 months of age; infant birthweight between 2500g and 4000g; infant gestational age is at least 36 weeks
Exclusion Criteria:
- non-English-speaking; infant with serious disease or disorder affecting growth and nutrition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Response
|
Parents pick from a menu of behavior changes
|
|
Other: Non-response
|
Stepped up phone interaction with parents based on menu of behavior changes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Satisfied or Very Satisfied With Information Given to Them, as Measured by Follow up Questionnaire
Time Frame: 3 to 6 months after baseline assessment
|
Completed Likert scale with 1=very unsatisfied, 2=unsatisfied, 3=neutral, 4=satisfied, 5=very satisfied
|
3 to 6 months after baseline assessment
|
|
Percentage of Successful Contacts With Families Via Telephone and/or in Clinic
Time Frame: 3 to 6 months after baseline assessment
|
Number of successful contacts with families divided by number of attempts to contact by research staff x 100
|
3 to 6 months after baseline assessment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent of Participants Exclusively Breastfeeding at 4 Months Postnatal Age
Time Frame: 3 to 6 months after baseline assessment
|
Dyad caregivers were asked what type of milk was being consumed by the infant, with 4 options available: 1) Formula only, 2) Mostly formula and some breast milk, 3) Mostly breast milk, but some formula, or 4) Breast milk only.
|
3 to 6 months after baseline assessment
|
|
Percent of Participants Delaying Complementary Feeding Until 4 Months Postnatal Age
Time Frame: 3 to 6 months after baseline assessment
|
Dyads caregivers were asked, "Is your baby eating solid foods yet or do you put any solid foods in the bottle?", with 2 options available: 1) Yes or 2) No
|
3 to 6 months after baseline assessment
|
|
Percent of Participants Reporting "Never" Engaging in Screentime While Feeding and With '0' Minutes of Active TV Watching at 4 Months Postnatal Age
Time Frame: 3 to 6 months after baseline assessment
|
Dyad caregivers were asked "I watch TV or look at or use my phone while feeding my baby" and responded with one of 5 Likert-scale responses: 1) Never, 2) Seldom, 3) Half of the time, 4) Most of the time, 5) Always
|
3 to 6 months after baseline assessment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Charles Wood, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 7, 2020
Primary Completion (Actual)
May 4, 2021
Study Completion (Actual)
May 4, 2021
Study Registration Dates
First Submitted
December 30, 2019
First Submitted That Met QC Criteria
December 30, 2019
First Posted (Actual)
January 2, 2020
Study Record Updates
Last Update Posted (Actual)
November 16, 2022
Last Update Submitted That Met QC Criteria
October 21, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Pro00102738
- U54MD012530 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Standard response
-
M.D. Anderson Cancer CenterCompleted
-
University of California, Los AngelesBiotronik, Inc.TerminatedCongenital Heart Disease | Bradycardia SinusUnited States
-
Centre Hospitalier Universitaire DijonRecruiting
-
Ye ShengNot yet recruitingOut-of-Hospital Cardiac Arrest (Simulated)China
-
University of PittsburghPatient-Centered Outcomes Research InstituteCompletedPneumonia | Sepsis | Covid19 | Lower Resp Tract InfectionUnited States
-
Kanuni Sultan Suleyman Training and Research HospitalNot yet recruitingBronchopulmonary Dysplasia (BPD) | Mortality Prediction | Chloride DisorderTurkey
-
University of UtahThe University of Texas Health Science Center at San AntonioCompletedSuicidal Ideation | SuicideUnited States
-
University of South-Eastern NorwayCompleted
-
AdventHealthCompletedPain | Pancreatic CancerUnited States
-
Yale UniversityNational Institute of Neurological Disorders and Stroke (NINDS)CompletedAutism Spectrum DisordersUnited States